✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
Mr. Ahmed is a 72-year-old retired accountant who lives with his daughter. Over the past 6–8 months, she has noticed a gradual but progressive decline in his energy level and daily functioning. Previously independent, he now spends most of the day seated, naps frequently, and has reduced interest in social activities he once enjoyed. He denies chest pain or dyspnea but reports persistent fatigue and a ‘heavy’ feeling in his limbs.
He frequently complains of feeling cold, even when other family members are comfortable. He has begun wearing layered clothing indoors and uses extra blankets at night. His daughter also reports that his speech has become slower and somewhat slurred, with longer pauses between words. He appears less expressive facially and occasionally seems forgetful, though he denies confusion.
Past Medical History
Myocardial
infarction 8 months ago, treated with percutaneous coronary intervention
Type 2
Diabetes Mellitus (15-year history)
Epilepsy
(well-controlled, no seizures in 5 years)
Medications
Aspirin
81 mg daily
Atorvastatin
40 mg nightly
Metoprolol
succinate 50 mg daily
Lisinopril
10 mg daily
Metformin
1000 mg twice daily
Phenytoin
300 mg daily
No recent medication changes have been reported. Adherence is described as consistent.
Physical Examination
Appears fatigued, slow to respond but oriented. Speech is slowed with mild
dysarthria.
Vital
Signs:
Blood
Pressure: 128/74 mmHg
Heart
Rate: 54 bpm
Respiratory
Rate: 14/min
Temperature:
36.1°C
Dry, coarse, cool to touch; mild non-pitting edema of hands.
Periorbital puffiness; thinning of the lateral eyebrows.
Thyroid gland not visibly enlarged; no nodules palpated.
Bradycardic but regular rhythm; no murmurs.
Delayed relaxation phase of deep tendon reflexes; mild proximal muscle
weakness; slowed mentation but intact cognition.
No tremor; mild non-pitting edema.
Laboratory Findings
12 mIU/L (0.45–4.5 mIU/L)
Free
T4:
0.3 ng/dL (0.8–1.7 ng/dL)
Questions
1. Provide a definitive diagnosis for Mr. Ahmed’s thyroid status, classifying the specific type of disorder based on the laboratory findings. (2 marks)
2. Identify three signs or symptoms from his presentation that support your finding. (3 marks)
3. Formulate a specific initial therapy and dosing regimen for Mr. Ahmed (medication name, dose and frequency). Justify your dose selection. (5 marks)
4. Analyze the potential pharmacological interactions between Mr. Ahmed's existing medications and the initiated therapy. What adjustments might be necessary? (2 marks)
Outline the clinical plan for titrating
Mr. Ahmed’s dose. Include the specific dosage increments and the timeframe
between adjustments with reasoning. (3 marks)